2 Stocks From Lombardia You Must Buy: Coach, Inc. (COH), Metlife Inc (MET), Duke Energy Corp (DUK)

Page 1 of 2

The first thing that pops up in my mind whenever I read about Lombardia Capital Partners is that it is a successful 100% employee-owned investment firm. The firm mostly capitalizes on stocks that are undervalued because of the speculative investors. It maintains a well diversified portfolio with a focus on Financial and Service sector stocks, which represent ~50% of the firm’s assets. Analyzing the decline in its positions in the last 13F filings, I came up with three interesting stocks. The firm liquidated its holdings in Coach, Inc. (NYSE:COH), Metlife Inc (NYSE:MET) and Duke Energy Corp (NYSE:DUK). I feel that decreasing its holding in Coach was a wise step by Lombardia, but both MetLife and Duke could have provided long term growth in the future, and the firm should have increased its position instead.  Let’s discuss each of them in detail.

Company Percentage Decrease
Coach Incorporated 13.00%
MetLife Incorporated 10.00%
Duke Energy Corporation 6.00%

Source: Whalewisdom.com

Coach, Inc. (NYSE:COH)

Coach

The stock price of Coach trembled down by ~15% since it declared its 2Q13 results. Despite the holiday season, the company’s North American Region sales (which contributes ~72% to the total revenue) had a negative same-store-sales (SSS) growth of ~2% Y/Y. North American sales were affected by intensified competition, heavy discounting, and Hurricane Sandy. On the other side, weakness in the Japanese Yen also caused a decline in the sales revenue from the region, and even more headwinds are expected in the currency throughout FY13. These factors dragged down the overall sales growth to just 3.8% Y/Y. Additionally, I am not optimistic about the company’s guidance for revenue in the second half of FY13.

It will be quite difficult for the company to either achieve a high single digit sales growth rate or a ~10% square footage growth in the second half of 2013 considering the flat comp rate for North America.

Coach is increasingly losing customers to its competitors; for instance, for the first time it lost its share in the women’s handbag segment, where a ~10% growth was expected. Looking at the brighter side, Coach expects to open 65 new stores next year, and 30 of them are planned for mainland China. Coach’s Chinese region performance showed a ~40% growth in sales, and the company expects to achieve total revenue of ~$400 million in FY13. However, I feel that this won’t be enough to pull up the stock in the short term. The stock is a Sell for me.

MetLife

Recently MetLife sold its deposit business to GE Capital. As a result it transferred $6.4 billion in bank deposits to GE Capital. The sale shows the increasing focus of MetLife on its core business, i.e., insurance and employee benefits. This deal also allowed the company to initiate the de-registration process, and the company is about to exit from the regulations applicable on a bank holding company. This is a very critical move for the company, seeing as it failed the stress test last year. The Federal Reserve restricted it from declaring any dividend or conducting any share buyback. The company declared in its guidance that a long term Return on Equity of ~12% is expected from its business. However, it should be noted here that it still holds the position of a Non-Bank SIFI, and some Federal regulations do apply on the company. Hence, the company can repurchase on a single day up to 25% of the four-week average volume of shares traded in the market. Considering the current price, it is expected that the company can repurchase ~2.6 million shares in the next quarter worth ~$2 billion.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!